This site is intended for Healthcare Professionals only.

New product name, same powerful anti-inflammatory pain relief

Date:

Share post:

Voltarol Gel has introduced product name changes to help patients and pharmacy professionals find the appropriate product for their needs. The formulations have stayed the same.

Voltarol 12 Hour Joint Pain Relief 2.32% Gel is now called Voltarol Max Strength Pain Relief 2.32% Gel and is available as a pharmacy pack. The 100g pack contains an easy open flip top cap. The formulation is also available in smaller pack sizes for the GSL fixture as Voltarol Joint & Back Pain Relief 2.32% Gel.

Voltarol Max Strength Pain Relief Gel contains diclofenac, a potent NSAID. The topical gel targets the inflamed area to relieve pain at its source instead of masking it. Voltarol relieves pain, reduces inflammation, and speeds recovery. The 2% strength gel offers the convenience of all-day pain relief for joints, muscles, sprains and strains, when applied twice daily.

You can find out more about the Voltarol range and access pharmacy education resources at this website.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Medicine shortages: UK charities and pharmacists call for supply chain review

‘Unless there is openness and transparency between the government and manufacturers, resolving medicine shortages will remain impossible’ Health charities...

Europe Sees Surge in Generic Medicines Withdrawals; UK Faces Doubling of Drug Shortages

Generic medicines for cancer and mental health on the Union List of Critical Medicines are disappearing, study reveals...

NHS to support newly-trained pharmacists with new £1.5 million investment

The new initiative is set to create highly-skilled placement opportunities in community pharmacies, GP surgeries, and care homes...

Professor Mahendra Patel joins UK Pharmacy Professional Leadership Advisory Board

The nine independent expert members of the UK Pharmacy Professional Leadership Advisory Board announced   Professor Mahendra Patel OBE,...